[india-drug] Response to use of anti retroviral drugs in India

[Rahman S Z <rahmansz@sancharnet.in>]

Response to use of anti retroviral drugs in India
---------------------------------------------------------------

Provision of antiretroviral therapy in resource-limited settings:
a review of experience up to August 2003

WHO and the UK's Department for International Development

Authors: Kathy Attawell and Jackie Mundy

This paper was developed by HSRC on behalf of DFID and in collaboration

with the World Health Organization (WHO). Special thanks are due to the

following individuals and organizations for their contributions: the
DFID-funded HIV/AIDS Knowledge Programme at Imperial College and the
Liverpool School of Tropical Medicine; Matt Boxshall, Lighthouse Trust;
Kate Butcher (JSI);Charles Lacey, Imperial College; Jos Perriens, WHO;
Eric van Praag, Family Health International (FHI); Oscar Picazo, World
Bank.

This background paper aims to increase understanding of the 
requirements for
introducing and scaling up provision of antitetroviral therapy (ART) as

part
of comprehensive HIV/AIDS programmes in resource-poor countries. The 
paper
provides an overview of experience and lessons learned with regard to:
* The feasibility of ART in resource-poor settings.
* The different approaches being taken to delivery of ART.
* The issues to be considered in scaling up ART provision.

The review is based on published and unpublished literature, interviews

with
key informants, web searches and country information. It also draws on 
a
review conducted by the Health Systems Resource Centre (HSRC) and John 
Snow
International (JSI) for the Government of Kenya in late 2002 (under the

DFID
supported HAPAC Project managed by the Futures Group) and a review of 
the
impact of HIV on health systems conducted by HSRC and JSI in early 
2003.

You can download the document from the WHO website:
http://www.who.int/3by5/publications/documents/dfid/en/
(scroll to the bottom of the page for the link to the document)

*******************
S. Ziaur Rahman, MD
Aligarh



________________________________________________________________________
Yahoo! India Mobile: Download the latest polyphonic ringtones.
Go to http://in.mobile.yahoo.com

Access Essential Drugs Monitor #32 at http://www.who.int/medicines/mon/mon32.shtml

The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@healthnet.org